This relaxed state naturally increases the risk of aspiration, where the stomach contents may enter the throat and lungs
Are there age restrictions
There were also no significant changes in the slowness criteria measure using gait speed between the L-carnitine and placebo groups
EP0983300B1 - Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy - Google Patents Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy Download PDF Info Publication number EP0983300B1 EP0983300B1 EP98929345A EP98929345A EP0983300B1 EP 0983300 B1 EP0983300 B1 EP 0983300B1 EP 98929345 A EP98929345 A EP 98929345A EP 98929345 A EP98929345 A EP 98929345A EP 0983300 B1 EP0983300 B1 EP 0983300B1 Authority EP European Patent Office Prior art keywords nabpc157 disturbances salt peptide bpc Prior art date Legal status (The legal status is an assumption and is not a legal conclusion
While common adverse effects such as gastrointestinal symptoms are well documented ( Statements Data availability statement The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author
The most common side effects include nausea, vomiting, diarrhea, stomach pain, low appetite (which the drug is meant to cause), fatigue, and dizziness
